Surprisingly, only 14 (10%) patients reported the use of immunosuppressive systemic therapy for their HS including prednisone, azathioprine, cyclosporine, and/or biologic therapies (e.g., TNF-α inhibitors). The gene discussed is TNF; the disease is histiocytic sarcoma.